Pfizer, a major American pharmaceutical company, is expected to apply for approval in Japan on the 18th for the new coronavirus vaccine it has developed, according to an interview with the people concerned.
This is the first time that an application for approval has been submitted in Japan for a new coronavirus vaccine.
Pfizer has collaborated with a German company to develop a new coronavirus vaccine, which has already begun in the United States and the United Kingdom.
Pfizer has reached a basic agreement with the Ministry of Health, Labor and Welfare to supply vaccines for 60 million people to Japan by the end of June next year, and has conducted clinical trials in Japan as well.
According to the people concerned, the results of the clinical trial have already been finalized, and it is expected that an application for approval will be submitted to the Ministry of Health, Labor and Welfare on the 18th.
This is the first time that an application for approval of a new coronavirus vaccine has been submitted in Japan.
Pfizer has announced that it has been found to be 95% effective in the final effect analysis of clinical trials conducted around the world, and the Ministry of Health, Labor and Welfare will examine the efficacy and safety in the future. You will decide whether to approve it.